4/26/2006 | BT | Boston Scientific gets $7 billion credit facility
|
3/29/2006 | BT | Guidant suspends Xience V supply, stops enrollment in Spirit 3 trial
|
3/28/2006 | BT | Medtronic sues Guidant in Ireland in ongoing stent patent infringement battle
|
3/21/2006 | BT | Guidant to create new patient safety officer post, put product performance reports online
|
3/17/2006 | BT | Guidant enrolls first patient in carotid artery stenting study
|
3/15/2006 | BT | Guidant completes enrollment in U.S. portion of drug eluting stent pivotal trial
|
3/14/2006 | BT | Guidant study says carotid artery stenting can be performed by variety of doctors
|
3/13/2006 | BT | Guidant advises physicians about Renewal cardiac defibrillators, possible FDA recall
|
2/27/2006 | BT | Analyst updates cardiology market from East Coast session
|
2/23/2006 | BT | FDA completes inspection of Guidant's St. Paul facilities, notes one observation
|
2/13/2006 | BT | Moody's cuts Boston Scientific, may lower Guidant
|
1/30/2006 | BT | Guidant receives CE Mark for drug eluting coronary stent
|
1/25/2006 | BT | S&P may downgrade Guidant
|
1/25/2006 | BT | JMP maintains Guidant at market perform
|
1/25/2006 | BT | Boston Scientific, Guidant sign merger agreement valued at $27 billion
|
1/24/2006 | BT | Guidant receives European recommendation for approval of drug-eluting stent
|
1/23/2006 | BT | Guidant finds more faulty pacemakers
|
1/17/2006 | BT | Boston Scientific's improved $80 per share offer accepted by Guidant
|
1/13/2006 | BT | Johnson & Johnson ups offer for Guidant to $71 a share
|
1/12/2006 | BT | Guidant reiterated by JMP at market perform
|
1/12/2006 | BT | Boston Scientific ups offer for Guidant
|
1/11/2006 | BT | Johnson & Johnson raises bid to $23.2 billion to acquire Guidant, says both boards agree on deal
|
1/11/2006 | BT | S&P puts Guidant on developing watch
|
1/10/2006 | BT | Guidant says no new FDA complaints about its St. Paul facility
|
1/10/2006 | BT | JMP maintains Guidant at market perform
|
1/9/2006 | BT | Boston Scientific adds twist to $25 billion Guidant offer - selling vascular business to Abbott for $3.8 billion
|
1/6/2006 | BT | JMP: St. Jude, Medtronic best bets in medical device stocks; still wary of orthopedics
|
1/5/2006 | BT | Guidant maintained by JMP at market perform
|
12/30/2005 | BT | Guidant gets warning letter from FDA about St. Paul facility
|
12/7/2005 | BT | Guidant's board to begin talks with Boston Scientific about $25 billion acquisition offer
|
12/5/2005 | BT | Boston Scientific offers $25 billion to buy Guidant, topping Johnson & Johnson's offer
|
12/5/2005 | BT | S&P may cut Boston Scientific, up Guidant
|
12/5/2005 | BT | Fitch may cut Boston Scientific; Guidant view evolving
|
12/5/2005 | BT | Market Commentary: Noven soars on ADHD patch news; Ligand bounces on board expansion; Progenics off sharply
|
11/15/2005 | BT | S&P changes Guidant watch to developing
|
11/15/2005 | BT | Moody's affirms Guidant
|
11/15/2005 | BT | Fitch up Guidant watch to positive
|
11/10/2005 | BT | Guidant completes enrollment in Xience V drug-eluting stent trial
|
11/7/2005 | BT | Moody's may lower Guidant
|
11/7/2005 | BT | Market Commentary: Solid earnings fuel ViroPharma stock; Guidant sues Johnson & Johnson over proposed merger
|
11/2/2005 | BT | S&P changes Guidant watch to developing
|
11/2/2005 | BT | Fitch puts Guidant on evolving watch
|
10/31/2005 | BT | Guidant launches wireless heart failure system
|
10/20/2005 | BT | Moody's changes Guidant to direction uncertain
|
7/5/2005 | BT | Market Commentary: Voyager plans IPO; Able Labs plunges; Mylan Labs launch seen; Boston Scientific up, J&J lower
|